---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000513"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:30:42.489881+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Daré Bioscience posts updated corporate presentation; no material new info disclosed

## Summary
- Filed under Item 7.01; presentation available on company website and as Exhibit 99.1.
- No specific financial or operational updates provided in the filing body.
- Presentation content not available for review; confidence in material new facts is low.

## SEC filing metadata
- accession: 0001493152-26-000513
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226000513/0001493152-26-000513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226000513/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000513
- JSON: https://secwatch.observer/filing/0001493152-26-000513.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000513.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.